All In MedTech

FDA Clearance Tracker · P040020-S050

ACRYSOF IQ RESTOR +2.5 D MULTIFOCAL INTRAOCULAR LENS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 13, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 13, 2015

Approved

Time to decision

591 days

Received Aug 30, 2013. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P040020-S050
Device name
ACRYSOF IQ RESTOR +2.5 D MULTIFOCAL INTRAOCULAR LENS
Applicant location
Fort Worth, TX
Received
Aug 30, 2013
Decided
Apr 13, 2015
Decision
Approved
Supplement type
Panel Track
Original approval
P040020

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code MFK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ACRYSOF® IQ RESTOR® +2.5 D MULTIFOCAL INTRAOCULAR LENS (IOL), MODEL SV25T0. THIS DEVICE IS INDICATED FOR PRIMARY IMPLANTATION IN THE CAPSULAR BAG OF THE EYE FOR THE VISUAL CORRECTION OF APHAKIA SECONDARY TO REMOVAL OF A CATARACTOUS LENS IN ADULT PATIENTS WITH AND WITHOUT PRESBYOPIA, WHO DESIRE NEAR, INTERMEDIATE AND DISTANCE VISION WITH INCREASED SPECTACLEINDEPENDENCE.

Source documents

Other decisions for Alcon Research, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.